Virtual screening reveals 1,2,3-triazole-phthalimide derivatives as potent antiviral candidates for COVID-19.
exhibited excellent interaction values and inhibitory potential against SAR-Cov-2 main protease and viral nucleocapsid proteins, suggesting this derivative as a potent antiviral for the treatment and/or prophylaxis of COVID-19.Communicated by Ramaswamy H. Sarma.
No takes yet. Share an insight, caveat, or question.
Holanda et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: